The CAR-T Landscape: Innovations, Challenges, and Future Directions
Have already registered
| Last name | First name | Organization |
|---|---|---|
| Buytaert | Dimitri | Janssen Pharmaceutica NV |
| Campion | Françoise | CSL Behring |
| Guarini | Nadia Pia | HR One Group BV |
| Janssens | Kristel | HealthA BV |
| Khaoutieva | Albina | Enterprise Ireland |
| Kinoo | Dominique | AstraZeneca nv/sa |
| Leloup | Roxane | Nuwhï |
| Lodewijckx | Inge | ELI LILLY Benelux sa/nv |
| Mergan | Stephanie | HEBIAS bv |
| Paternotte | Nathalie | AstraZeneca nv/sa |
| Ronsse | Damien | Galapagos NV |
| Van den Daele | Kristin | IQVIA |
| Van den Eede | Caroline | Amgen Belgium nv |
| Van Dooren | Patrick | IQVIA |
| Van Rompaey | Philippe | UZ Gent - HIRUZ |
| Vancaeneghem | Pieter | GILEAD Sciences Belgium bv |
| Vandewiele | Frone | Kintiga (AxTalis BV) |
| Verheyen | Anne | CSL Behring |
| Vermeersch | Evelyne | Ad Hoc Clinical NV |
| Wambacq | Liske | Nuwhï |
| Weglewski | Tim | IQVIA |
| Willems | Micha | IQVIA |
| Winters | Karen | Novartis |